MIFEPRISTONE AND MISOPROSTOL

Brand name:

• MS-2 Step®

Pharmaceutical company:

MS Health Pty Ltd

Condition/indication:
(therapeutic use)

• Termination of an intrauterine pregnancy

PBAC Submission type:

Change to PBS listing (Category 3)

Comment:

--

Public Summary Document:

PBAC Public Summary Documents – March 2023

Related medicines:

--

Submission received for:

March 2023 PBAC meeting

Opportunity for consumer comment:

Open 23/11/2022 and close 25/01/2023 (see PBS Website)

PBAC meeting:

Held on 08/03/2023

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

05/06/2023

Lodgement of required documentation:

21/06/2023

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 03/07/2023

Status:

Finalised

Government processes:

Commenced on 03/07/2023

Medicine listed on the PBS:

01/08/2023 (see PBS schedule)

---